Parry's, part of the massive Murugappa Group, promotes its Spirulina dietary supplement as approved by the U.S. Food and Drug Administration. It's ad headline reads: "U.S. FDA -- The ingredients of the better Spirulina."
But Sanat Products, a subsidiary of the Dabur group, has filed a complaint about that ad to the Advertising Standards Council of India and is countering Parry's FDA claim with what it calls a "public interest ad."
"Consumers of Spirulina do not be misled," its headline announces, followed by copy stating: "The U.S. FDA does not approve Spirulina ... for human consumption in the USA."
Parry's response: It has filed its own complaint with the ASCI.
Copyright December 2000, Crain Communications Inc.